Evercore ISI Group Maintains Outperform on Insulet, Lowers Price Target to $180
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Daniel Markowitz maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $200 to $180.
Evercore ISI Group analyst Daniel Markowitz maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $200 to $180.